#Rapid Diagnostic Market

[123567-9qaaq9]

Infectious Disease Rapid Diagnostic Testing is primarily adopted for the diagnosis of various infectious diseases in a restricted clinical environment. These testing primarily relies on the detection of the target analyte, offering clinical insights in a stipulated time frame. Such testing is becoming an integral component of the healthcare system across the globe. 

[healthcaremarketanalysis]

Point of Care Diagnostics Market worth $77.8 billion by 2028

The global point-of-care diagnostics market, valued at $49.7 billion in 2023, is projected to reach $77.8 billion by 2028, growing at a CAGR of 9.4%. Key drivers include the rising prevalence of infectious diseases like influenza, HIV, and tuberculosis, supportive government policies, and the shift towards healthcare decentralization. Challenges include pricing pressures due to reimbursement cuts and stringent regulatory approvals. Significant growth opportunities exist in emerging markets like China, India, Brazil, and Mexico. In 2022, glucose monitoring products held a significant market share, with lateral flow assays leading by platform. Major players include Abbott Laboratories, F. Hoffman-La Roche Ltd., BD, Danaher Corporation, and Siemens Healthineers. Recent developments feature FDA approvals for new diagnostic panels by bioMérieux and BD, and a partnership between Thermo Fisher Scientific and Project HOPE to expand HIV testing in Sub-Saharan Africa.

Download an Illustrative overview:

Browse in-depth TOC on "Point of Care Diagnostics Market"

191 - Tables

51 - Figures

322 – Pages

The Lateral Flow Assays segment, by platform, is expected to register the largest market share of the global point of care diagnostics industry in 2022.

Based on platform, the point-of-care diagnostics market is segmented into lateral flow assays, immunoassays, microfluidics, dipsticks, and molecular diagnostics. The lateral flow assays segment dominated this market with a share of in 2022.Lateral flow assays are simple in usage, relatively inexpensive, making it more accessible for patients and healthcare provider, LFA technology does not require trained person to operate, allowing them to be used in various healthcare settings, from clinics and pharmacies to  remote arears, promoting healthcare decentralization. All these factors are contributing towards the dominance of lateral flow technology in point of care diagnostics market.

The OTC testing product segment, by mode of purchase, to dominate the global point of care diagnostics industry in 2022.

On the basis of mode of purchase OTC testing products segment accounted the largest market share in 2022 attributed to the increasing adoption of OTC products owing to its ease of usage and convenience. The presence of diverse range of OTC point of care devices for diseases screening, personal health monitoring and various other conditions further contribute to the rising demand for OTC PoC testing devices among consumers.

North America to account for the largest share of point of care diagnostics industry during the forecast period.

North America is the expected to be the largest regional market for point of care diagnostics during the forecast period. The presence of a well-established healthcare system, rapid adoption of advanced point of care testing products, increase in the availability of medical reimbursement, favourable government support for the novel product development, and higher user awareness about the presence of point of care testing products are anticipated to support the market growth in the region

Request Sample Pages:

Point of Care Diagnostics Market Dynamics:

Drivers:

Rising incidence of infectious diseases

Increasing prevalence of target conditions

Favorable government initiatives for POC testing

Rising number of CLIA-waived POC tests

Restraints:

Pricing pressure on POC manufacturers

Stringent regulatory approval process for product commercialization

Opportunities:

High growth potential of emerging markets

Decentralization of healthcare

Innovative product development

Challenge:

Inadequate standardization with centralized lab methods

Limited awareness in emerging markets

Premium pricing of novel platforms

Key Market Players of Point of Care Diagnostics Industry:

As of 2022, the point of care diagnostics market was dominated by Abbott Laboratories (US), F. Hoffmann-La Roche Ltd. (Switzerland), Siemens Healthineers (Germany), Danaher Corporation (US), and Becton, Dickinson and Company (US)

Point of Care Diagnostics Market - Key Benefits of Buying the Report:

The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies for strengthening their market presence.

This report provides insights on the following pointers:

Analysis of Key divers (rising prevalence of infectious and chronic disease, growing adoption of self-testing kits, helathacre decentralization, rising number of CLIA-wavier Poc Tests), restraints (rising pricing pressure on PoC manufactures, stringent regulatory approval procedures for new PoC devices), Opportunities (emerging markets, emerging technologies, such s microfluidics) , Challenge (Training & education in low resource countries)

Market Penetration: Comprehensive information on the product portfolios offered by the top players in the point-of-care diagnostics market

Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the point-of-care diagnostics market

Market Development: Comprehensive information on lucrative emerging regions

Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the point-of-care diagnostics market

Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.

Related Links:

[athenese-dx]

Celebrating 10 Years' Journey of Athenese-Dx Pvt. Ltd.

celebration #10years #athenesedx #Chennai #IVD #India #milestone

🎉 Celebrate a Decade of Innovation with Athenese-Dx! Join us in our 10th Anniversary Celebration as we continue to honor a decade of groundbreaking achievements at Athenese-Dx. This special video takes you on a journey through our most memorable moments, showcasing our commitment to excellence and innovation.

Highlights:

Milestone Moments: Relive our top achievements and how they've shaped the industry. From pioneering diagnostic technologies to life-changing breakthroughs, we've been at the forefront of medical advancements.Behind-the-Scenes: Get an exclusive look at the people and passion driving our success. Meet our brilliant scientists, dedicated researchers, and tireless support staff who have fueled our journey.Future Forward: Peek into the future as we unveil exciting plans for the next decade. Discover our vision for improving patient care, expanding global reach, and revolutionizing healthcare.

Thank You to Our Community: We extend our heartfelt gratitude to our customers, partners, and employees who have been part of our story. Your unwavering support and trust have propelled us forward.

Stay Connected: Don't miss out on any updates as we embark on the next chapter of our journey

diagnosticcenter #rapidtest #elisakit #biochemistry #ivdmanufacturing #clinicalchemistry #ivdinstrument #medicaldevices #reagents

Together, let's continue to redefine diagnostics and transform lives. Here's to the next ten years of excellence! 🥂 🎉 Cheers to many more amazing years! 🎉

ATHENESE-DX PRIVATE LIMITED Address: Module No. 407 & 408, 4th Floor, TICEL Bio Park II, No. 5, CSIR Road, Taramani, Chennai, Tamil Nadu - 600113, India

For Inquires - WhatsApp +917397238924 Click here to chat: https://wa.me/917397238924

For Reviews & News, go to https://www.athenesedx.com/

Follow us on WhatsApp Channel: https://whatsapp.com/channel/0029Va8M7HQChq6HfUBMLj0X

🌎 Visit our office - https://qr.page/g/5lZXERbP8Av

🤝 Subscribe - https://youtube.com/@athenesedx Our early diagnosis products for a better life. Thank you for your support.

🔔 For more videos, products, reviews ↷ YouTube ▶ https://youtube.com/@athenesedx

🌐 For more information ↷ Website ▶ https://athenesedx.com To Buy Athenese-Dx Products ▶ https://store.athenesedx.com

📱 Follow us on social media ↷ Facebook ▶ https://www.facebook.com/Athenese.Dx.Pvt.Ltd/ Instagram ▶ https://www.instagram.com/athenese_dx/ Pinterest ▶ https://www.pinterest.com/athenesedx/ X (Twitter) ▶ https://twitter.com/athenesedx Tumblr ▶ https://www.tumblr.com/athenese-dx LinkedIn ▶ https://www.linkedin.com/company/athenese-dx-private-limited/ Medium ▶ https://medium.com/@athenesedx01

[wivbkwjcla]

The global rapid medical diagnostic kits market was USD 14.36 Billion in 2022 and is expected to reach USD 17.16 Billion in 2032, and register a revenue CAGR of 2% during the forecast period. 

[cmipooja]

Global Poultry Diagnostics Market Is Estimated To Witness High Growth Owing To Increasing Adoption of Molecular Diagnostic Tests

The global Poultry Diagnostics Market is estimated to be valued at US$ 536.7 million in 2023 and is expected to exhibit a CAGR of 11.4% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Poultry diagnostics refer to the testing and detection of various diseases and infections in poultry farms. These diagnostics play a crucial role in preventing and managing the spread of diseases amongst poultry animals, such as chickens and turkeys. The market for poultry diagnostics is driven by the increasing demand for poultry products, rising concerns about food safety, and the need for early and accurate diagnosis of diseases to prevent economic losses for farmers. Poultry diagnostics also help in improving animal welfare and overall productivity. Market Key Trends: One key trend in the global poultry diagnostics market is the increasing adoption of molecular diagnostic tests. Molecular diagnostic tests, such as PCR (polymerase chain reaction) and DNA sequencing, offer high sensitivity and specificity in detecting and identifying various infectious diseases in poultry animals. These tests enable rapid diagnosis, identification of pathogens, and monitoring disease outbreaks. For instance, Bioingentech, a key player in the poultry diagnostics market, offers molecular diagnostic kits for avian influenza virus detection. PEST Analysis: - Political: Government regulations play a significant role in the poultry industry. Stringent rules regarding food safety and disease control drive the demand for poultry diagnostics. - Economic: The demand for poultry products is increasing worldwide due to population growth and rising disposable incomes. This fuels the need for efficient disease management through diagnostics. - Social: Consumer awareness about food safety and the importance of disease-free poultry products is growing, leading to the adoption of poultry diagnostics. - Technological: Advancements in diagnostic technologies, such as point-of-care testing and real-time PCR, are revolutionizing the poultry diagnostics market. These technologies offer faster and more accurate results. Key Takeaways: Paragraph 1: The Global Poultry Diagnostics Market Demand is expected to witness high growth, exhibiting a CAGR of 11.4% over the forecast period, due to increasing adoption of molecular diagnostic tests. These tests provide rapid and accurate detection of infectious diseases, ensuring timely disease management and prevention of economic losses for farmers. Paragraph 2: The North America region is expected to dominate the global poultry diagnostics market, primarily driven by the presence of major market players, well-established poultry industry, and strict regulations on food safety. Asia Pacific is expected to be the fastest-growing region due to the increasing demand for poultry products and the need for efficient disease management in densely populated countries like China and India. Paragraph 3: Key players operating in the global poultry diagnostics market include Zoetis, Thermo Fisher Scientific Inc., Baltivet, Bioingentech, Devex, BioChek, QIAGEN, Bioneer Corporation, Megacor Diagnostik GmbH, Merck & Co., Inc., IdentiGEN, Abaxis, BIOMERIEUX, Transasia Bio-Medicals, Boehringer Ingelheim International GmbH, EW Group Ltd., and Hygiena, LLC. These players focus on product innovation, strategic collaborations, and acquisitions to gain a competitive edge in the market.

[everythingwaschocolateandsugar]

From Glass to Plastic: Understanding the Evolution of Blood Collection Tubes

The Global Blood Collection Tubes Market report provides insight into global economies as well as business perspectives on macroeconomic factors affecting the market. A detailed breakdown of the market structure, as well as significant business trends and challenges, is included in the report. This research report also analyzes historical data and future business opportunities in the global blood collection tubes market.

Request for sample PDF: https://www.nextmsc.com/Blood-Collection-Tubes-Market/request-sample

Business cycles, demographics, and microeconomic requirements have been evaluated in this report to comprehensively understand the global blood collection tubes market. Furthermore, the global blood collection tubes market study specifies an in-depth analysis of the current business circumstances. This study report also evaluates a variety of financial factors like production value, growth rate, and key regions in order to identify ways to increase the company's revenue.

The following key players dominate the blood collection tubes market:

Becton, Dickinson and Company

Greiner Bio One International GmbH

Streck Inc.

SiO2 Materials Science

QIAGEN

McKesson Medical-Surgical Inc.

FL MEDICAL s.r.l.

Haemonetics Corporation

AdvaCare Pharmaceuticals

Sarstedt AG & Co.

Narang Medical Limited

A list of the largest players in the global blood collection tubes market is provided in this report, allowing you to gain a deeper understanding of those companies. In order to educate businesses about growing their business, this data will be of benefit to both existing and emerging companies.

Throughout the world, production facilities have struggled due to strict lockdowns imposed by the COVID-19 pandemic.

Furthermore, certain prominent players experienced a drop in demand for their products as a result of changes in consumer behavior toward their spending patterns. As the industry recovers from the pandemic, the global blood collection tubes market is expected to grow significantly in revenue by the year 2030.

There have been various research methodologies used for the global analysis of the blood collection tubes market, including primary and secondary research, PESTEL and SWOT analyses, and Porter's five forces model, among others. It has been the objective of this study to provide a better understanding of prices, costs, revenues, and numbers using statistics and figures, and tables.

Sales, demand, product advancements, and production capacity are covered in this report, as well as a comprehensive overview of the blood collection tubes market. Additionally, the report analyzes various segments of the global blood collection tubes market, as well as supply chains, distribution chains, and company execution across regional markets. This report will help prominent as well as new entrants in this industry to assess their production, marketing, and sales approaches.

By Type, the blood collection tubes market can be categorized into:

Plasma Separating Tube

Serum Separating Tube

Heparin Tubes

EDTA Tubes

Rapid Serum Tubes

Others 

In terms of End User, the market for blood collection tubes is further divided into:

Hospitals and Clinics

Research Centers

Diagnostic Laboratories

Others 

Several aspects of this industry are included in the global blood collection tubes market research report, including future growth prospects, business plans, and sales figures. The focus of this report is on forecasted market sizes as well as market shares of companies in the blood collection tubes market. As a result, several economic and social factors have a greater impact on the business than they have ever been. In this study report, critical information is provided to assist businesses in developing effective strategies for promoting their products and services.

Using the information in this report, companies can formulate business plans and strategies based on the changing market trends by analyzing market dynamics and perspectives. By understanding the market trends and dynamics, companies will be able to grow and stay competitive. To ensure the validity of the data quoted in this report, scientific papers and other credible sources were reviewed.

Furthermore, the report includes forecasts about growing companies in the industry based on their segmentation by region. According to the geographical regions, this research examines the global markets in North America, Europe, Asia-Pacific, Latin America, Africa, and the Middle East. Essentially, it examines future revenue potentials and trends in business and how businesses can benefit from technology advancements.

About Us

Next Move Strategy Consulting is a premier market research and management consulting firm. We are committed to providing strategically-analyzed and well-documented research reports to our customers. What makes us different from the rest is our top-quality research and the obsession with turning data into knowledge by analyzing it thoroughly and providing fact-based research recommendations. We collect information from over 500 million websites, paid databases, industry journals, and one-on-one consultations with industry experts across various sectors. The high-quality customized research reports with actionable insights and excellent end-to-end customer service also help our customers make critical business decisions and gain a competitive edge in the industry.

We have serviced over 1,000 customers globally, including 90% of the Fortune 500 companies over a decade. Our analysts constantly track various high-growth markets and identify hidden opportunities in each sector or industry. We provide one of the best syndicated and custom research reports across 10 different industry verticals. Our industry-standard delivery solutions range from pre-consultation to after-sales services. We offer an excellent customer experience and help our customers make strategic business decisions.

Source: Next Move Strategy Consulting

[healthcaremarketanalysis]

The global point-of-care diagnostics market, valued at $49.7 billion in 2023, is projected to reach $77.8 billion by 2028, growing at a CAGR of 9.4%. Key drivers include the rising prevalence of infectious diseases like influenza, HIV, and tuberculosis, supportive government policies, and the shift towards healthcare decentralization. Challenges include pricing pressures due to reimbursement cuts and stringent regulatory approvals. Significant growth opportunities exist in emerging markets like China, India, Brazil, and Mexico. In 2022, glucose monitoring products held a significant market share, with lateral flow assays leading by platform. Major players include Abbott Laboratories, F. Hoffman-La Roche Ltd., BD, Danaher Corporation, and Siemens Healthineers. Recent developments feature FDA approvals for new diagnostic panels by bioMérieux and BD, and a partnership between Thermo Fisher Scientific and Project HOPE to expand HIV testing in Sub-Saharan Africa.

[covid-safer-hotties]

Do At-Home COVID-19 Tests Still Work? - Published Sept 6, 2024

These days, many people use at-home COVID-19 tests when they feel ill, rather than going out to get tested by a professional. (That’s when they bother to test at all.) But for all their convenience, the antigen tests commonly used at home have never been as accurate as PCR tests done in a lab—and the continued mutation of the virus raises additional concerns about their performance.

Rapid COVID-19 tests have never been perfect. How are they holding up as new variants emerge?

The U.S. Food and Drug Administration (FDA) continues to monitor the efficacy of the diagnostics it regulates—and as of August 2023, the FDA said none of the antigen tests on the market were expected to have reduced performance against Omicron or its subvariants. (All of the variants that have emerged since late 2021, including recent ones like KP.3.1.1, are relatives of the original Omicron strain.)

The FDA has also collaborated with a U.S. National Institutes of Health task force set up to monitor how variants affect tests. In 2022, well into Omicron's dominant era, that team concluded that DIY diagnostics continued to work well. Task force member Richard Creager wrote in an email to TIME that the tests still seem able to catch the Omicron spinoffs that are circulating now. “The rapid tests are having no issue detecting the variants,” he wrote, noting that the protein that antigen tests look for has remained fairly stable as the virus changes.

Even if tests have remained constant, our immune systems haven’t. Early in the pandemic, an infected person's “viral load”—the amount of virus in their system—tended to peak around the time their symptoms began. So if someone self-tested on the first or second day they felt sick, they likely had enough virus in their body for a rapid test to detect it.

Now that most everyone has prior immunity from multiple vaccines or infections, the timeline seems to be extended. Viral load now tends to peak around day four or five of symptoms, according to a study published in early 2024. That’s likely because the immune system is primed for action by its previous encounters with the virus, so it responds faster, even before lots of virus has built up in the body. A quicker immune response may mean a faster onset of symptoms.

“If your body has seen the virus before, you’re going to react to it and have an immune response more quickly,” explains study co-author Dr. Nira Pollock, co-director of the Infectious Diseases Diagnostic Laboratory at Boston Children’s Hospital. “That immune response can show up as symptoms.”

From an immune perspective, that’s a good thing. But it can complicate testing, because it means someone may not test positive for COVID-19 until they’ve already been feeling sick for days. In their recent study, Pollock and her co-authors estimated that a COVID-19 antigen test is somewhere between 30% and 60% accurate at detecting an infection on someone’s first day of symptoms, but up to 93% accurate on day four.

Based on such findings, Pollock and other researchers cautioned in a recent review article that people who are symptomatic shouldn’t assume they’re COVID-free based on a single negative antigen test result. Although it's a hard sell for people who no longer take precautions, the ideal scenario is for someone to stay isolated—or at least wear a mask when around other people—and test again around day four of symptoms.

“The instructions for these tests are to do serial testing,” Pollock says. “If you’re symptomatic, you should test early. But if you’re negative, you need to repeat it, because the amount of virus in your nose may not be high enough yet to detect.”

One other factor to consider: tests don’t last forever. Many people stockpiled tests when they were previously available for free through government programs and insurance, and those kits may have since expired. (You’ll soon be able to order four more free tests through the government.) The FDA’s website provides up-to-date guidance on determining how long your kits last.

Expired tests can still work, says Dr. Zishan Siddiqui, an assistant professor at the Johns Hopkins University School of Medicine. He co-authored a 2023 study on Abbott’s popular BinaxNOW tests, which found no major accuracy differences between unexpired tests and those that were five months past expiration. (Siddiqui’s other research suggests unexpired BinaxNOW tests accurately detect COVID-19 cases more than 80% of the time.)

But, although Siddiqui says he isn't too worried about using expired tests, it’s good to remember that their performance can suffer if they’re long past their recommended use dates. If the control line on your test strip doesn’t show up or looks distorted, that’s a good indication that it’s too old to use, he says. Even in Siddiqui's study, which found that expired tests still work, the lines on the old tests showed up more faintly than on fresh tests, making them harder to read.

Whether your tests are old or brand new, it’s good to use some healthy skepticism when interpreting their results. “I trust these tests,” even as the virus evolves, Siddiqui says—but a single result doesn’t always tell the whole story. If you have COVID-like symptoms but test negative, it’s best to be cautious and retest in a few days.

[trendtrackershq]

𝐃𝐫𝐢𝐯𝐢𝐧𝐠 𝐏𝐫𝐨𝐠𝐫𝐞𝐬𝐬: 𝐀𝐝𝐯𝐚𝐧𝐜𝐞𝐦𝐞𝐧𝐭𝐬 𝐢𝐧 𝐀𝐧𝐢𝐦𝐚𝐥 𝐓𝐡𝐞𝐫𝐚𝐩𝐞𝐮𝐭𝐢𝐜𝐬 𝐚𝐧𝐝 𝐃𝐢𝐚𝐠𝐧𝐨𝐬𝐭𝐢𝐜𝐬 𝐌𝐚𝐫𝐤𝐞𝐭

As the landscape of animal health continues to evolve, we’re thrilled to see the remarkable advancements in Animal Therapeutics and Diagnostics!

𝐆𝐞𝐭 𝐚 𝐅𝐑𝐄𝐄 𝐒𝐚𝐦𝐩𝐥𝐞: https://www.nextmsc.com/animal-therapeutics-and-diagnostics-market/request-sample?utm_source=sanyukta-14-may-2024&utm_medium=sanyukta-tumblr&utm_campaign=sanyukta-animal-therapeutics-and-diagnostics-market

𝐃𝐢𝐚𝐠𝐧𝐨𝐬𝐭𝐢𝐜 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧𝐬:

Cutting-edge diagnostic tools are revolutionizing how we understand and address animal health concerns. From rapid testing kits to advanced imaging technologies, these innovations empower veterinarians and researchers to make informed decisions quickly and accurately. By detecting diseases earlier and with greater precision, we're enhancing the well-being of our furry friends and contributing to a healthier world.

𝐓𝐡𝐞𝐫𝐚𝐩𝐞𝐮𝐭𝐢𝐜 𝐁𝐫𝐞𝐚𝐤𝐭𝐡𝐫𝐨𝐮𝐠𝐡𝐬:

The realm of animal therapeutics is witnessing unprecedented breakthroughs, with novel treatments emerging to address a diverse range of conditions. Whether it's targeted therapies for chronic diseases or innovative approaches to pain management, these advancements are improving the quality of life for animals across the globe. It's inspiring to see how science and compassion intersect to create solutions that make a tangible difference.

𝐆𝐥𝐨𝐛𝐚𝐥 𝐈𝐦𝐩𝐚𝐜𝐭:

The impact of these advancements extends far beyond individual animals; it influences entire ecosystems and strengthens the bond between humans and animals. By promoting the health and well-being of our animal companions, we're safeguarding biodiversity, supporting sustainable agriculture, and enhancing public health. Together, we're shaping a brighter future for all living beings.

𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬:

The animal therapeutics and diagnostics industry consist of a number of major players including BioNote Inc, Heska Corp, IDEXX Laboratories Inc, IDvet, Randox Laboratories Ltd., SWISSAVANS AG, Teco Diagnostics, Thermo Fisher Scientific Inc., Virbac SA, Zoetis Inc., Thermo Fisher Scientific, Inc., bioMérieux S.A., Zoetis Inc., Bio-Rad Laboratories, Inc., Medical Bioscience GMBH, and Agrolabo SpA

Let's continue to champion innovation, collaboration, and compassion in the field of Animal Therapeutics and Diagnostics!

Together, we can create a world where every animal receives the care and attention it deserves.

[spinupthepornograph]

cw: some robotgirl non-con/dub-con.

You take your robot girl's personality card out, and she goes ragdoll.

You clip it into the new adapter that just arrived from aliexpress, then dig through some drawers and pull out a few more personality cards, clicking them all into the slots. The whole assembly goes back into your robogirl's chassis, and you wait a moment for the diagnostic lights to turn green.

You pull out the remote from the dusty package, and stick in a fresh battery. A single button press and the adapter clicks, and an LED blinks a few times. You close up her chassis and and long-press the power button on the back of her neck.

All her servos jerk momentary, then the light in her eyes comes back. Unfocused eyes look around rapidly, then see you, and she smiles.

"Master! Are you done with my upgrade?" "I sure am, my pet. Want to see what I've added?" "Of course, master!".

You help her to her feet, then tell her to stay there. You step back, and click the remote. Her eyes go fuzzy for a second, then come back. She drops to all fours, tongue lolling out of her mouth. She pants, looking up at you expectantly. You pull a tennis ball from your pocket, and gently toss it out the open workshop door and down the hallway.

She excitedly arfs and races out the door, still on all fours. You hear her rooting around the packages waiting around the door, then she emits a muffled happy "yip!" and there's the sound of rapid quadrupedal footsteps as she scrambles back into the room. She kneels at your feet, dropping the slightly-wet tennis ball at your feet, and looking up at you, smiling as wide as she can but saying nothing.

You tap the remote, and again she seems to fuzz out of it for a moment, and you hear the soft click of a relay turning over inside her. She looks around in confusion, and gets back up on her feet. "Master, what... why did I do that? I remember searching for the ball and bringing it back to you, but I don't remember why I did that! It's like I'm remembering someone else's memories!"

You show her the flimsy piece of paper that came with the adapter, and she quickly scans the badly auto-translated english text.

TELPO PM-04 Personality Multiplexer

attach every personality cards into slots A, B, & C, D

insert the card proxy into any Syntek Central Unit (48 only pin)

On attached remote, button press to select toggle active personality card slot

Use only CR3220 cell

Memory Storage is reserved to slot A, other cards will share space

"A personality multiplexer, master?" she says, looking up at you with some confusion.

"Yep! I can swap your consciousness out for one of my choice. Slot B has this.". You hand her the small box, and she goes over it quickly, turning it over in her hands. It's covered in pictures of puppies, and advertises an accurate simulation of a loving "pupper", compatible with any Syntek chassis on the market.

"You turned me into a dog?!"

You rarely get her flustered enough to forget to address you properly. It's cute, though you'll have to punish her later for it. It might be your imagination, but you swear you can hear her fans spinning a little faster at the revelation...

"More or less. I pretty much just put you on pause, while letting a different personality take over your body. And I can do that at the click of a button!" You hold up the remote, showing her the four unlabeled buttons. "Want to see what's in slot C?" You reach towards the button, intentionally slowly...

She reaches out her arms "No! I mean, No thanks, master. Maybe I can look at the boxes first? I'd like to know more about what I'll be before we test it out."

You smile as devilishly as you can manage. "I don't know, that doesn't sound like something little dolls get to choose. Maybe you'd enjoy some time as a mindless sexbot?" Her already-big eyes manage to go wider, and she reaches forward for the remote impudently. You slam the button, and she stops mid-reach.

A moment later, she drops to her knees, and opens her mouth. She says nothing, as sexbots don't need speech synthesis routines. "I'm going to have a lot of fun with this", you think. Mainly in making her remember what you're going to make her do... You unzip your fly, and she leans forward hungrily.